色覚異常の世界市場-2023年～2030年

概要

色覚異常市場は、その普及率の増加により、近年著しい成長を遂げています。色覚異常は色覚障害とも呼ばれ、通常は遺伝子変異によって遺伝します。色覚異常の予防法はありませんが、さまざまな種類の特殊眼鏡、コンタクトレンズ、視覚補助具を使用することで対処できます。治療は主に色覚異常のタイプに基づいて行われます。

色覚異常は通常、目の錐体が正常に働いていない場合に起こります。錐体には、目に入ってきた光や映像を処理し、色を知覚するための信号を脳に送る機能があります。クリーブランド・クリニックによると、青黄色覚異常は1万人に1人、無色視は3万人に1人、青錐体単色症は10万人に1人の割合で発症します。

色覚異常の有病率の増加、意識の高まりと早期発見、色覚異常メガネの需要の増加、研究開発活動の増加、技術進歩が、予測期間中に世界の色覚異常市場を牽引すると予想される主な要因です。

ダイナミクス

色覚異常用メガネの需要増加が色覚異常市場の成長を牽引

技術や研究活動の著しい進歩により、ユーザーにより正確な色知覚を提供する、より強化され、よりよく設計された色覚異常メガネや色覚矯正メガネが開発されました。色覚異常用メガネの品質と効果が向上するにつれて、色覚異常用メガネの需要は継続的に増加しています。

例えば、2022年7月27日、アイウェア・プラットフォームのEyeMyEyeは、インド初の色覚異常メガネを発表しました。これらは通常、赤緑色覚異常で苦しむ人々のために、色のコントラストと視覚の鮮やかさを強化し、改善する最先端の技術を用いて作られています。

色覚異常メガネは、多くの色覚異常の個人に非侵襲的な解決策を提供します。医学的な治療は副作用や合併症を引き起こす可能性がありますが、この色覚異常メガネは使用者に合わせて簡単に使用したり外したりすることができます。また、オンラインでもオフラインでも色覚異常用メガネを幅広く入手できるため、色覚異常用メガネの需要をさらに促進しています。

意識の高まりと早期発見も色覚異常市場の成長を促す

啓発キャンペーンや啓蒙活動は、教育や色覚異常の識別の増加につながり、これらの啓蒙プログラムは、治療法の利用可能性についても人々を教育します。色覚異常の啓発日は毎年9月6日で、この日が選ばれたのはジョン・ダルトンの誕生日にちなんでおり、彼は色覚異常の存在を最初に確認した人物です。

例えば、2022年9月1日、色覚異常用メガネを開発したエンクロマ社は、9月の国際色覚異常啓発月間の開始を発表しました。EnChroma社と50を超える博物館、図書館、学校区、州立・連邦公園、大学、観光機関、ライオンズクラブやキワニスクラブが、色覚異常（色覚障害）について会員、学生、地域社会、フォロワーを教育するために、ソーシャルメディアへの投稿やその他のコミュニケーションを行いました。

この啓発は色覚異常の早期発見につながり、タイムリーな介入を可能にします。これは色覚異常を持つ人々、特に教育現場や色の認識が重要な場面で役立ちます。早期介入には、色覚異常用メガネ、スマートフォンアプリ、コンタクトレンズ、またはその他の補助技術の進歩を利用して、色を正確に識別できるようにすることが含まれます。

限られた治療オプションが市場の成長を妨げる

現在、色覚異常に対する特別な治療法はないため、患者は日常生活で課題に直面する可能性がありますが、特殊な眼鏡、視覚補助器具、コンタクトレンズを使用することで対処できます。FDAが承認した色覚異常の治療法は限られています。より良い管理のために現在も臨床試験や調査研究が行われていますが、色覚異常を改善するための効果的な治療オプションがないことが、市場の成長を妨げる大きな要因となっています。

治療オプションの不足は患者のニーズを満たさないことにつながり、色覚異常の患者は代替治療オプションを求めています。治療オプションが限られているため、製薬会社や調査による革新的な治療オプションへの投資も減少しています。このため、FDAが承認した治療法がなく、企業は臨床試験や研究活動から遠ざかり、結果として市場シェアを阻害することになります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 色覚異常用メガネの需要増加
    • 意識の高まりと早期発見
  • 抑制要因
    • 限られた治療オプション
  • 機会
    • 技術進歩
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析

第6章 COVID-19分析

第7章 タイプ別

• 赤緑色覚異常
  • 原始視
  • デューテラノピア
  • 原色異常
  • デューテラノマリー
• 青黄色覚異常
  • トリタノピア
  • トリタノマリー
• 完全色覚異常（単色症）
  • 青色錐体色覚異常
  • 杆体単色症（無色視）

第8章 治療法別

• 眼鏡・コンタクトレンズ
• 視覚補助具

第9章 エンドユーザー別

• 病院
• 眼科クリニック
• その他

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋
• 中東・アフリカ

第11章 競合情勢

• 競合シナリオ
• 市況/シェア分析
• M&A分析

第12章 企業プロファイル

• Bausch and Lomb Corporation
  • 企業概要
  • 製品ポートフォリオと説明
  • 財務概要
  • 主な動向
• Carelust Ltd
• CooperVision, Inc.
• EnChroma, Inc.
• ColorLite GmbH
• VINO Optics
• Eyemyeye Pvt Ltd
• Covisn
• Pilestone Inc.
• SportRx

第13章 付録

Overview

The color blindness market is experiencing significant growth in recent years owing to its increasing prevalence. Color blindness is also known as color vision deficiency usually inherited through a genetic mutation. There is no prevention for color blindness but can manage by using different types of special glasses, contact lenses, and visual aids. The treatment is mainly based on the type of color blindness.

Color blindness usually happens when eye cones aren't working properly. Cones have the ability to process light and images as they enter the eye and send signals to the brain that allow them to perceive color. According to the Cleveland Clinic organization, blue-yellow color deficiency affects 1 in 10,000 people, achromatopsia affects 1 in 30,000 people, and blue cone monochromacy affects 1 in 100,000 people.

Owing to the increasing prevalence of color blindness, rising awareness and early detection, increasing demand for color blindness glasses, increasing research and development activities, and technological advancements are the major factors expected to drive the global color blindness market over the forecast period.

Dynamics

Increasing Demand for Color Blindness Glasses Drive the Growth of the Color Blindness Market

There are significant advancements in technology and research activities, which led to the development of enhanced and well-designed color blindness glasses or color correcting glasses which provides more accurate color perception for the users. As the quality and effectiveness of color blind glasses improve, the demand for these color blindness glasses continuously increases.

For instance, on July 27, 2022, EyeMyEye, an eyewear platform introduces India's first-ever range of Color Blind Glasses. These are usually crafted using the most advanced technology that enhances and improves color contrast and visual vibrancy for people suffering from Red-Green Color Blindness.

Color blindness glasses offer non-invasive solutions to many color blind individuals. The medical treatments may result in side effects and complications but these color blindness glasses can be easily used and removed according to the user. And there is also a wide availability of color blind glasses both online and offline, further driving the demand for color blind glasses.

Rising Awareness and Early Detection Also Drive the Growth of the Color Blindness Market

Awareness campaigns and awareness initiatives lead to increased education and identification of color blindness and these awareness programs also educate people about the availability of treatments. The date of color blindness awareness day is on September 06 every year, the day was chosen because of John Dalton's birthday, and he was the first person identified that color blindness existed.

For instance, on September 01, 2022, EnChroma, Inc., creators of glasses for color blindness announced the launch of International Color Blindness Awareness Month in September. EnChroma and over 50 museums, libraries, school districts, state and federal parks, universities, tourism agencies, and Lions and Kiwanis Clubs made social media posts and published other communications designed to educate their members, students, communities, and followers about Color Vision Deficiency (color blindness).

The awareness leads to early detection of color blindness and allows for timely intervention, which can be helpful for individuals with color blindness, especially in educational settings and where color recognition is critical. Early intervention involves using color blindness glasses, smartphone apps, contact lenses, or other assistive technological advancements to aid individuals in differentiating colors accurately.

Limited Treatment Options Will Hamper the Growth of the Market

Currently, there is no specific treatment for color blindness, this may impact the patients in facing challenges in daily life, but it can be managed by using special glasses, visual aids, and contact lenses. There are limited FDA-approved treatments available for color blindness management. While ongoing clinical trials and research efforts are still conducting for better management, the lack of effective therapeutic options for correcting color blindness has been a significant hampering factor in the market's growth.

The lack of the treatment options can lead to unmet patient needs, and individuals with color blindness seek alternative treatment options. The limited treatment options can also result in the reduced investments in innovative treatment options from pharmaceutical companies and researchers. This leads to an absence of FDA-approved medical treatment which discourages the companies from clinical trials and research activities, resulting in hampering the market share.

Segment Analysis

The global color blindness market is segmented based on type, treatment, end-user, and region.

The Red-Green Color Blindness From the Type Segment Accounted For Approximately 47.2% of the Color Blindness Market Share

The red-green color blindness is a common type of color blindness. In this type of color blindness, the cone cells are mainly responsible for recognizing the red and green colors that lack light-sensitive pigments, this is because they are not well-developed and do not function normally. The individuals who are affected by this type of color blindness find it challenging to pick out red and green colors in any given situation.

There are several sub-types of red-green color blindness, including protanopia, deuteranopia, protanomaly, and deuteranomaly. Red-green color blindness is usually more common in men compared to women. For instance, according to the colorblind awareness organization, color blindness (color vision deficiency) affects approximately 1 in 12 men (8%) and 1 in 200 women

This type of color blindness is because the genes for the color vision cone light-sensitive proteins are on the X chromosome, of which males have one and females have two. So, men are more common than women, due to one X in a male containing abnormal genes, color blindness will reveal itself, while females can compensate with the other normal gene on the second X chromosome.

For instance, on July 12, 2021, EnChroma, Inc., creators of glasses for color blindness announced the first safety glasses for the estimated 350 million people in the world who are color blind. The new line of EnChroma Safety Glasses is designed to help people with red-green color blindness overcome daily frustrations and obstacles in the workplace related to correctly identifying and interpreting colors.

Geographical Penetration

North America Accounted for Approximately 39.1% of the Market Share in 2022, Owing to the Increasing Prevalence and Strong Presence of Major Players

North America has a high prevalence of color blindness mainly due to their high population. Usually, color blindness affects a large portion of the global population, and North America is the most dominated region. For instance, according to the Iristech statistics, it is estimated that, in the United States, color blindness affects one in every 12 males and less than one in every 200 females.

North America region, especially the United States and Canada is home to major pharmaceutical companies, optical developers, and manufacturers specializing in healthcare including ophthalmology. This presence of major global players in the market ensures a wide range of color correcting glasses and other color aiding solutions for the management of color blindness, contributing to the dominance of the North America Region.

For instance, on August 01, 2023, RAZ Mobility, the leading provider of mobile assistive technology, announced the launch of the SmartVision 3. This Google-certified smartphone, manufactured by Kapsys, is designed specifically for individuals who are blind, color-blind, or visually impaired.

Competitive Landscape

The major global players in the color blindness market include Bausch and Lomb Corporation, Carelust Ltd, CooperVision, Inc., EnChroma, Inc., ColorLite GmbH, VINO Optics, Eyemyeye Pvt Ltd, Covisn, Pilestone Inc., and SportRx among others.

COVID-19 Impact Analysis

The COVID-19 pandemic significantly impacted the global color blindness market. During the pandemic, the healthcare systems were primarily focused on managing the COVID-19 cases, this inturn led to a shift in priorities and resources away from non-urgent medical conditions. As a result, the attention and investment in color blindness treatments and research might have been affected. The research activities and clinical trials on color blindness are also postponed due to the pandemic.

Russia-Ukraine Conflict Analysis

The Russia-Ukraine conflict is estimated to have a moderate impact on the global color blindness market, owing to the low prevalence and absence of key market players in the region. However, the impact of the import and export of raw materials and color blind glasses, contact lenses is expected to have little influence over the global color blindness market growth over the forecast period.

By Type

• Red-Green Color Deficiency
  • Protanopia
  • Deuteranopia
  • Protanomaly
  • Deuteranomaly

• Blue-Yellow Color Deficiency
  • Tritanopia
  • Tritanomaly

• Complete Color Blindness (Monochromacy)
  • Blue Cone Monochromacy
  • Rod Monochromacy (Achromatopsia)

By Treatment

• Glasses And Contact Lenses
• Visual Aids

By End-User

• Hospitals
• Ophthalmic Clinics
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico

• Europe
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Rest of Europe

• South America
  • Brazil
  • Argentina
  • Rest of South America

• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific

• Middle East and Africa

Key Developments

• On June 25, 2023, Samsung Electronics announced the addition of SeeColors mode on its 2023 TV and monitor lineup. The newly added accessibility feature provides various color settings based on degrees and types of color vision deficiency (CVD), offering an improved viewing experience.
• On June 13, 2023, Detroit River International Wildlife Refuge and EnChroma, creators of glasses for color blindness announced a collaboration to improve the experience for color-blind visitors to the Detroit River International Wildlife Refuge (DRIW). Guests who are red-green color blind can now use newly installed special SeeCoast viewer scopes, adapted with EnChroma lenses for color blindness, to enjoy nature in the Refuge in clear, vibrant color for the first time.
• On August 4, 2022, The Sumaira Foundation, a nonprofit organization focused on the rare neuroimmune diseases of NMOSD and MOGAD, is pleased to announce that it is joining forces with the Connor B. Judge Foundation (CBJF), a nonprofit started in 2014 to raise awareness and support research for NMOSD and other related autoimmune disorders. NMOSD stands for neuromyelitis optica spectrum disorder, a rare autoimmune neurological condition in which the immune system attacks cells in the central nervous system (CNS). Common symptoms include vision loss, color vision deficiency, paralysis, and others.

Why Purchase the Report?

• To visualize the global color blindness market segmentation based on type, treatment, end-user, and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of color blindness market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global color blindness market report would provide approximately 53 tables, 54 figures, and 195 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Type
• 3.2. Snippet by Treatment
• 3.3. Snippet by End-User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing Demand for Color Blindness Glasses
    • 4.1.1.2. Rising Awareness and Early Detection
  • 4.1.2. Restraints
    • 4.1.2.1. Limited Treatment Options
  • 4.1.3. Opportunity
    • 4.1.3.1. Technological Advancements
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's 5 Forces Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID-19
  • 6.1.2. Scenario During COVID-19
  • 6.1.3. Scenario Post COVID-19
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During the Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 7.1.2. Market Attractiveness Index, By Type
• 7.2. Red-Green Color Deficiency *
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.2.3. Protanopia
  • 7.2.4. Deuteranopia
  • 7.2.5. Protanomaly
  • 7.2.6. Deuteranomaly
• 7.3. Blue-Yellow Color Deficiency
  • 7.3.1. Tritanopia
  • 7.3.2. Tritanomaly
• 7.4. Complete Color Blindness (Monochromacy)
  • 7.4.1. Blue Cone Monochromacy
  • 7.4.2. Rod Monochromacy (Achromatopsia)

8. By Treatment

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
  • 8.1.2. Market Attractiveness Index, By Treatment
• 8.2. Glasses And Contact Lenses *
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Visual Aids

9. By End-User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.1.2. Market Attractiveness Index, By End-User
• 9.2. Hospitals *
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Ophthalmic Clinics
• 9.4. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.6.1. U.S.
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.6.1. Germany
    • 10.3.6.2. U.K.
    • 10.3.6.3. France
    • 10.3.6.4. Spain
    • 10.3.6.5. Italy
    • 10.3.6.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.6.1. Brazil
    • 10.4.6.2. Argentina
    • 10.4.6.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.6.1. China
    • 10.5.6.2. India
    • 10.5.6.3. Japan
    • 10.5.6.4. Australia
    • 10.5.6.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Bausch and Lomb Corporation *
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. Carelust Ltd
• 12.3. CooperVision, Inc.
• 12.4. EnChroma, Inc.
• 12.5. ColorLite GmbH
• 12.6. VINO Optics
• 12.7. Eyemyeye Pvt Ltd
• 12.8. Covisn
• 12.9. Pilestone Inc.
• 12.10. SportRx

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us